BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canaparo R, Foglietta F, Barbero N, Serpe L. The promising interplay between sonodynamic therapy and nanomedicine. Adv Drug Deliv Rev 2022;189:114495. [PMID: 35985374 DOI: 10.1016/j.addr.2022.114495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gu L, Duan Z, Li X, Li X, Li Y, Li X, Xu G, Gao P, Zhang H, Gu Z, Chen J, Gong Q, Luo K. Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy. Bioact Mater 2023;26:102-15. [PMID: 36875053 DOI: 10.1016/j.bioactmat.2023.02.015] [Reference Citation Analysis]
2 Roy S, Roy J, Guo B. Nanomaterials as multimodal photothermal agents (PTAs) against 'Superbugs'. J Mater Chem B 2023;11:2287-306. [PMID: 36857688 DOI: 10.1039/d2tb02396b] [Reference Citation Analysis]
3 Kim SJ, Lee G, Hong G, Yun SH, Hahn SK. Advanced light delivery materials and systems for photomedicines. Adv Drug Deliv Rev 2023;194:114729. [PMID: 36764457 DOI: 10.1016/j.addr.2023.114729] [Reference Citation Analysis]
4 Fan CH, Wu N, Yeh CK. Enhanced sonodynamic therapy by carbon dots-shelled microbubbles with focused ultrasound. Ultrason Sonochem 2023;94:106342. [PMID: 36842213 DOI: 10.1016/j.ultsonch.2023.106342] [Reference Citation Analysis]
5 Foglietta F, Macrì M, Panzanelli P, Francovich A, Durando G, Garello F, Terreno E, Serpe L, Canaparo R. Ultrasound boosts doxorubicin efficacy against sensitive and resistant ovarian cancer cells. Eur J Pharm Biopharm 2023;183:119-31. [PMID: 36632905 DOI: 10.1016/j.ejpb.2023.01.005] [Reference Citation Analysis]
6 Kim M, Kim D, Jang Y, Han H, Lee S, Moon H, Kim J, Kim H. Development of a Polymersome-Based Nanomedicine for Chemotherapeutic and Sonodynamic Combination Therapy. Int J Mol Sci 2023;24. [PMID: 36674707 DOI: 10.3390/ijms24021194] [Reference Citation Analysis]
7 Youden B, Jiang R, Carrier AJ, Servos MR, Zhang X. A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano 2022;16:17497-551. [PMID: 36322785 DOI: 10.1021/acsnano.2c06337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]